The spectrum of neuropathology in COVID-19
We are extremely proud to announce that the EAN Congress has been named Best Corporate Event Subject to a Fee for the second consecutive year at the Evento Awards in Finland.
Latest Posts
-
-
Breaking newsCOVID-19ResearchEvaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia -
Breaking newsCOVID-19ResearchThe impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society membership
The impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society membership -
COVID-19 case fatality and Parkinson’s disease
-
Neuro-ophthalmic manifestations of coronavirus disease 19
-
Risk factors for intracerebral hemorrhage in patients with COVID‐19 -
Multiple sclerosis and COVID‐19: how many are at risk?
-
Breaking newsCOVID-19Research
Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19
Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19 -
Breaking newsCOVID-19ResearchIncreased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis
Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis -
Breaking newsCOVID-19Research
Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts
Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts -
Breaking newsCOVID-19ResearchStroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases
Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases -
Breaking newsCOVID-19
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome studies in 8 stuporous and comatose patients
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome studies in 8 stuporous and comatose patients -
Breaking newsCOVID-19Research
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong -
Breaking newsCOVID-19Research
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 -
Breaking newsCOVID-19Research
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19